GB1260886A - Process for aryloxymethylmorpholine derivatives - Google Patents

Process for aryloxymethylmorpholine derivatives

Info

Publication number
GB1260886A
GB1260886A GB5013069A GB5013069A GB1260886A GB 1260886 A GB1260886 A GB 1260886A GB 5013069 A GB5013069 A GB 5013069A GB 5013069 A GB5013069 A GB 5013069A GB 1260886 A GB1260886 A GB 1260886A
Authority
GB
United Kingdom
Prior art keywords
phenyl
compounds
prepared
chlorophenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5013069A
Other languages
English (en)
Inventor
Stanley Arnold Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to PL1970141132A priority Critical patent/PL88898B1/pl
Priority to US00044644A priority patent/US3712890A/en
Priority to JP45052316A priority patent/JPS5016795B1/ja
Priority to FI1718/70A priority patent/FI61890C/fi
Priority to SE7008505A priority patent/SE393377B/xx
Priority to YU1553/70A priority patent/YU35009B/xx
Priority to SU1451402A priority patent/SU382287A3/ru
Priority to CH936570A priority patent/CH539068A/de
Priority to CS4319A priority patent/CS167901B2/cs
Priority to NO2395/70A priority patent/NO135939C/no
Priority to DK318670A priority patent/DK143399C/da
Priority to ES380973A priority patent/ES380973A1/es
Priority to HUIE399A priority patent/HU162422B/hu
Publication of GB1260886A publication Critical patent/GB1260886A/en
Priority to US00299174A priority patent/US3857839A/en
Priority to SE7605248A priority patent/SE408419B/xx
Priority to NO762973A priority patent/NO137124C/no
Priority to YU2689/78A priority patent/YU40208B/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB5013069A 1969-06-20 1969-06-20 Process for aryloxymethylmorpholine derivatives Expired GB1260886A (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
PL1970141132A PL88898B1 (enExample) 1969-10-13 1970-06-06
US00044644A US3712890A (en) 1969-06-20 1970-06-08 Process for making 2-aryloxymethyl morpholines
JP45052316A JPS5016795B1 (enExample) 1969-06-20 1970-06-16
FI1718/70A FI61890C (fi) 1969-06-20 1970-06-17 Nytt foerfarande foer framstaellning av terapeutiskt anvaendbara 2-aryloximetylmorfoliner
SE7008505A SE393377B (sv) 1969-06-20 1970-06-18 Sett att framstella morfolinderivat
YU1553/70A YU35009B (en) 1969-06-20 1970-06-18 Process for preparing morpholine derivatives
SU1451402A SU382287A3 (enExample) 1969-10-13 1970-06-18
NO2395/70A NO135939C (enExample) 1969-06-20 1970-06-19
CS4319A CS167901B2 (enExample) 1969-10-13 1970-06-19
CH936570A CH539068A (de) 1969-06-20 1970-06-19 Verfahren zur Herstellung von Morpholinderivaten
DK318670A DK143399C (da) 1969-10-13 1970-06-19 Fremgangsmaade til fremstilling af morfolinderivater
ES380973A ES380973A1 (es) 1969-06-20 1970-06-20 Procedimiento para la preparacion de derivados de morfolina.
HUIE399A HU162422B (enExample) 1969-06-20 1970-06-20
US00299174A US3857839A (en) 1969-06-20 1972-10-19 For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
SE7605248A SE408419B (sv) 1969-10-13 1976-05-07 Sett att framstella morfolinderivat
NO762973A NO137124C (no) 1969-06-20 1976-08-30 Fremgangsm}te for fremstilling av morfolinderivater
YU2689/78A YU40208B (en) 1969-06-20 1978-11-17 Process for preparing morpholine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3125569 1969-06-20

Publications (1)

Publication Number Publication Date
GB1260886A true GB1260886A (en) 1972-01-19

Family

ID=10320364

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5013069A Expired GB1260886A (en) 1969-06-20 1969-06-20 Process for aryloxymethylmorpholine derivatives

Country Status (5)

Country Link
AT (1) AT300820B (enExample)
BR (1) BR6915221D0 (enExample)
CS (1) CS167902B2 (enExample)
GB (1) GB1260886A (enExample)
PL (1) PL92088B1 (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2575158A1 (fr) * 1984-12-20 1986-06-27 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
WO1998007710A1 (en) * 1996-08-23 1998-02-26 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
WO2005105763A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
US7132551B2 (en) 2000-09-11 2006-11-07 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
US8044052B2 (en) 2006-10-18 2011-10-25 Pfizer Inc. Biaryl ether urea compounds
WO2022198062A2 (en) 2021-03-18 2022-09-22 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof
WO2024206307A2 (en) 2023-03-27 2024-10-03 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2575158A1 (fr) * 1984-12-20 1986-06-27 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
EP0187096A1 (fr) * 1984-12-20 1986-07-09 Pierre Fabre Medicament Arylalcoyloxymethyl-2 morpholines, leur préparation et leur application en tant que médicaments utiles dans le traitement des troubles du système nerveux central
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
WO1998007710A1 (en) * 1996-08-23 1998-02-26 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
US6207662B1 (en) 1996-08-23 2001-03-27 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine D4 receptor antagonists
US6479491B1 (en) 1996-08-23 2002-11-12 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
US7132551B2 (en) 2000-09-11 2006-11-07 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
US7517892B2 (en) 2000-09-11 2009-04-14 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
US7816375B2 (en) 2000-09-11 2010-10-19 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
WO2005105763A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
US7659394B2 (en) 2004-04-30 2010-02-09 Pfizer Inc Substituted morpholine compounds for the treatment of central nervous system disorders
US8044052B2 (en) 2006-10-18 2011-10-25 Pfizer Inc. Biaryl ether urea compounds
WO2022198062A2 (en) 2021-03-18 2022-09-22 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof
WO2022198062A3 (en) * 2021-03-18 2022-10-27 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof
US11634415B2 (en) 2021-03-18 2023-04-25 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof
US11919889B2 (en) 2021-03-18 2024-03-05 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof
US12215097B2 (en) 2021-03-18 2025-02-04 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof
WO2024206307A2 (en) 2023-03-27 2024-10-03 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof

Also Published As

Publication number Publication date
BR6915221D0 (pt) 1973-02-13
CS167902B2 (enExample) 1976-05-28
PL92088B1 (enExample) 1977-03-31
AT300820B (de) 1972-08-10

Similar Documents

Publication Publication Date Title
GB1364619A (en) 1.2.4-triazole derivatives process for their production and their use as fungicides
GB1132082A (en) The manufacture of pyrimidine derivatives
GB1260886A (en) Process for aryloxymethylmorpholine derivatives
IE33092L (en) Piperidine derivatives
GB1171155A (en) Improvements in or relating to Cycloalkane Derivatives and the manufacture thereof
GB1310235A (en) Heterocyclyloxymethyl-morpholine or piperazine-derivatives
GB1391244A (en) 3-amino-1h-pyrazolo-3,4-b-pyridines and a process for their preparation
GB1364137A (en) 1,3,4-oxadiazolone derivatives
GB1413262A (en) 2-phenoxyalkylthio imidazoles and congeners
GB1159505A (en) Substituted Amino-s-Triazines and Curable Compositions Containing them
GB1236112A (en) 5,10-dihydro-11h-dibenzo[b,e][1,4]diazepine-11-ones
ATE58902T1 (de) Penem-derivate.
GB1209146A (en) Substituted tetraazaindene compounds and their use as stabilizers for photographic silver halide emulsions
GB1412546A (en) Morpholine derivatives
GB1136927A (en) 5-substituted-isoxazolidones and intermediates therefor
ATE55997T1 (de) Substituierte hydroxybutynylazole als pflanzenwachstumsregulatoren.
GB878628A (en) Improvements in or relating to the production of nitrofuran derivatives
GB1199680A (en) Triazole Compounds, processes for their manufacture and use
GB1137505A (en) Process for the production of azines and hydrazine
GB1269776A (en) Epoxides and halohydrins and conversion thereof to alkanolamine derivatives
ES319942A1 (es) Procedimiento para la obtencion de 3 ',4',5'-trimetoxi-3-aminoacrilofenona.
GB1213285A (en) Substituted s-triazines
GB1477347A (en) Substituted ureido-s-triazines and process for their pre paration
FR2234310A1 (en) Azido-tris (dialkylamino) phosphonium salts - as peptide-coupling agents giving high yields
GB1231081A (enExample)